Kestra Medical Technologies (KMTS) Cash from Financing Activities (2024 - 2026)
Kestra Medical Technologies (KMTS) posted quarterly Cash from Financing Activities of -$185000.0 for Q2 2026, down 100.09% year-over-year from $214.7 million in Q2 2025, and down 100.12% quarter-over-quarter from $149.2 million in Q1 2026.
Kestra Medical Technologies (KMTS) Cash from Financing Activities (2024 - 2026) Analysis & Trends
Kestra Medical Technologies (KMTS) has reported Cash from Financing Activities for 3 consecutive years, with -$185000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Cash from Financing Activities fell 100.09% year-over-year to -$185000.0; the TTM figure through Apr 2026 stood at $147.1 million (down 55.46% YoY), while the FY2026 annual figure was $147.1 million, down 55.46% from the prior year.
- Cash from Financing Activities eased to -$185000.0 in Q2 2026 per KMTS's latest filing, from $149.2 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $214.7 million in Q2 2025 and bottomed at -$1.9 million in Q3 2025.
- Historically, Cash from Financing Activities has averaged $54.4 million across 3 years, with a median of -$27000.0 in 2025.
- Annual changes were most pronounced in 2025 — Cash from Financing Activities sank 101.61% — and 2026, when it jumped 125463.03%.
- Kestra Medical Technologies' Cash from Financing Activities stood at -$575000.0 in 2024, then soared by 95.3% to -$27000.0 in 2025, then tumbled by 585.19% to -$185000.0 in 2026.
- Business Quant data shows KMTS's Cash from Financing Activities at -$185000.0 in Q2 2026, $149.2 million in Q1 2026, and -$27000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -287.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -577.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -510.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -263.16 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -159.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -300.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -75.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -31.00 Mn |
| 10 | Kestra Medical Technologies | 1.45 Bn | 1.10 Bn | 15.68 Mn | -185,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -185,000.00 |
| Apr 30, 2026 | -185,000.00 |
| Jan 31, 2026 | 149.18 Mn |
| Jan 31, 2026 | 149.18 Mn |
| Oct 31, 2025 | -27,000.00 |
| Oct 31, 2025 | -27,000.00 |
| Jul 31, 2025 | -1.88 Mn |
| Jul 31, 2025 | -1.88 Mn |
| Apr 30, 2025 | 214.70 Mn |
| Apr 30, 2025 | 214.70 Mn |
| Jan 31, 2025 | -119,000.00 |
| Jan 31, 2025 | -119,000.00 |
| Oct 31, 2024 | -575,000.00 |
| Oct 31, 2024 | -575,000.00 |
| Jul 31, 2024 | 116.25 Mn |
| Jul 31, 2024 | 116.25 Mn |
| Apr 30, 2024 | 12.24 Mn |
| Apr 30, 2024 | 12.24 Mn |